PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
NCT05803746
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Colorectal Cancer
Interventions
DRUG:
18F-FDG
Sponsor
Peking University Cancer Hospital & Institute